SNDL
SNDL
NASDAQ · Pharmaceuticals

Sndl Inc

$1.37
+0.01 (+0.74%)
As of Sep 20, 10:29 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +1,078.8% upside
Low Target $10.52
Average Target $16.15
High Target $19.28
Current Price $1.37
Current
$1.37
Target
$16.15
$10.52 $16.15 avg $19.28
Scenario Analysis
Bear Case
$10.52
667.9%
Low target
Base Case
$16.15
+1,078.8%
Avg target
Bull Case
$19.28
+1,307.3%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$2.89
-52.6% from high
52-Week Low
$1.17
+17.6% from low
Target vs 52W High
$16.15
+458.8% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +13.7%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.3%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +5.5%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +21.4%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +180.3%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +188.0%